Cargando…
Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder
BACKGROUND: Sulforaphane (SF), an isothiocyanate in broccoli, has potential benefits relevant to autism spectrum disorder (ASD) through its effects on several metabolic and immunologic pathways. Previous clinical trials of oral SF demonstrated positive clinical effects on behavior in young men and c...
Autores principales: | Zimmerman, Andrew W., Singh, Kanwaljit, Connors, Susan L., Liu, Hua, Panjwani, Anita A., Lee, Li-Ching, Diggins, Eileen, Foley, Ann, Melnyk, Stepan, Singh, Indrapal N., James, S. Jill, Frye, Richard E., Fahey, Jed W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146218/ https://www.ncbi.nlm.nih.gov/pubmed/34034808 http://dx.doi.org/10.1186/s13229-021-00447-5 |
Ejemplares similares
-
Correction to: Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder
por: Zimmerman, Andrew W., et al.
Publicado: (2021) -
Biomarker Exploration in Human Peripheral Blood Mononuclear Cells for Monitoring Sulforaphane Treatment Responses in Autism Spectrum Disorder
por: Liu, Hua, et al.
Publicado: (2020) -
Sulforaphane from Broccoli Reduces Symptoms of Autism: A Follow-up Case Series from a Randomized Double-blind Study
por: Lynch, Rhoda, et al.
Publicado: (2017) -
Developmental regression and mitochondrial function in children with autism
por: Singh, Kanwaljit, et al.
Publicado: (2020) -
Identification of urinary metabolites that correlate with clinical improvements in children with autism treated with sulforaphane from broccoli
por: Bent, Stephen, et al.
Publicado: (2018)